Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**OxyRub** is a branded over-the-counter topical analgesic cream product line for temporary relief of minor muscle and joint aches associated with arthritis, simple backache, strains, sprains, and bruises. The base OxyRub Pain Relief cream contains menthol 1.25% as its active ingredient; menthol produces a cooling counterirritant effect primarily through activation of the cold-sensing TRPM8 ion channel. Separate OxyRub MAX and OxyRub PRO formulations contain menthol 2.5% plus methyl salicylate 10%, but these are distinct combination formulations rather than synonyms for the single-ingredient OxyRub Pain Relief cream. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/search.cfm?query=65121-113))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OxyRub.